Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akebia Therapeutics, Inc. AKBA

Healthcare  —  Drug Manufacturers Specialty & Generic
0.90 (0.02) (2.17%) as of 25 Sep
Market cap
$254.7M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

 166.44 184.84 162.64 155.55
Receivables 66.22 47.03 62.54 53.51
Inventory 18.64 15.61 13.00 13.02
Total current assets 258.34 252.96 243.48 229.55
Property, Plant, Equpment (Net) 1.47 1.22 0.96 1.51
Goodwill and Intangible Assets (Total) 59.04 59.04 59.04 59.04
Long-term assets (Other) 40.46 59.68 56.57 53.75
Total non-current assets 105.82 123.61 119.04 120.11
Total Assets 364.15 376.57 362.52 349.66
Accounts Payable 10.09 21.19 8.39 9.42
Accrued Expenses 106.42 121.72 125.06 109.80
Current Part of Debt — — 12.50 24.81
Current Revenue (Deferred) 3.88 2.68 4.50 6.17
Other current liabilities 12.99 17.36 23.45 10.67
Total current liabilities 133.38 162.94 173.88 160.87
Long Term Debt (Total) 47.64 48.25 36.40 24.75
Non-current Liabilities (Other) 141.54 132.77 124.87 134.62
Total non-current liabilities 189.18 181.02 161.26 163.78
Total liabilities 322.56 343.96 335.15 324.64
Additional Paid In Capital 1,713.05 1,716.31 1,720.13 1,726.68
Common Stock (Net) 0.00 0.00 0.00 0.00
Retained Earnings (1,671.46) (1,683.70) (1,692.76) (1,701.67)
Common Equity (Total) 41.59 32.61 27.37 25.02
Shareholders Equity (Total) 41.59 32.61 27.38 25.02
Shareholders Equity and Liabilities (Total) 364.15 376.57 362.52 349.66
Shares (Common) 265.23 265.43 267.90 271.74
Shareholders Equity (Tangible) (17.45) (26.43) (31.67) (34.03)
Net Debt (118.80) (136.59) (113.75) (105.98)
Total Debt 47.64 48.25 48.89 49.56

Fold the line items

In millions of $ except per-share values · columns are period end dates